Valuation considerations related to the CARES Act

The Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, was enacted by Congress on March 27, 2020. Subsequently, interim guidance continues to be released by the Treasury and Small Business Administration (SBA). Presented below are FAQs which address questions arising in relation to business valuation, followed by a summary of four key CARES Act provisions with additional FAQs. The information provided below is not a substitute for the valuation analyst’s experience or professional judgement. Further research and analysis